GCG’s Q3 2025 Healthcare Industry Update provides an overview of the latest trends in the sector, including recent performance, valuation multiples, and the state of the middle-market M&A environment.

Key findings include the following:

• Healthcare continued to demonstrate strong resilience in Q3 2025, supported by lower interest rates, stable recurring revenue models, and demographic demand that helped sustain investor confidence despite ongoing regulatory scrutiny and selective dealmaking conditions.
• Q3 recorded 883 transactions, remaining above six-quarter averages, with strategic buyers driving 59% of total volume; medical and surgical supplies, assisted living, and retail/specialty pharmacy led activity as MedTech investment accelerated and aging-population demand continued to rise.
• Deal structures further evolved as buyers adapted to valuation uncertainty and regulatory pressures, with improved financing conditions enabling larger transactions while AI-driven healthcare platforms gained momentum, reflecting investor focus on efficiency, scalability, and high-visibility growth models.

See here for all Healthcare News and Updates

Get in Touch

Tell us a little about yourself and we will get in touch as soon as we can.